Personalised medicine — challenges of authorisation and reimbursement

Personalised medicine is a very promising and cutting-edge approach that Taylor Wessing recently discussed from a patent law perspective in its Synapse October edition.

In principle, personalised medicine refers to a classification of individuals into sub-populations that differ in their susceptibility to a particular disease or their response to a specific treatment. Preventive, diagnostic or therapeutic interventions can then be tailored to the individual characteristics of patients who will benefit, sparing expense and side effects to those who will not.

A predictive biomarker — such as a particular genetic characteristic, which is causally linked to the disease — can play a crucial role in classifying patients in sub-populations. As regards the suitable therapy with a medicinal product or a range of medicinal products, so-called companion diagnostics are essential to and specifically intended for the selection of patients with a previously diagnosed condition or predisposition. To date, more than 30 ‘personalised’ medicinal products are sold on the German market for which a prior diagnostic test is either mandatory or recommended…

If you are registered and logged in to the site, click on the link below to read the rest of the Taylor Wessing briefing. If not, please register or sign in with your details below.

Sign in or Register to continue reading this article

Sign in


It's quick, easy and free!

It takes just 5 minutes to register. Answer a few simple questions and once completed you’ll have instant access.

Register now

Why register to The Lawyer


Industry insight

In-depth, expert analysis into the stories behind the headlines from our leading team of journalists.


Market intelligence

Identify the major players and business opportunities within a particular region through our series of free, special reports.


Email newsletters

Receive your pick of The Lawyer's daily and weekly email newsletters, tailored by practice area, region and job function.

More relevant to you

To continue providing the best analysis, insight and news across the legal market we are collecting some information about who you are, what you do and where you work to improve The Lawyer and make it more relevant to you.

Briefings from Taylor Wessing

View more briefings from Taylor Wessing

Analysis from The Lawyer

  • merger deal

    Corporate crunch time: who will triumph at The Lawyer Awards 2014?

    As the equity capital markets rocketed back into favour and global M&A saw at least a partial return to form, there have been some rich pickings for The Lawyer’s Corporate Team of the Year award shortlisted firms in 2014. 

  • singapore orchid

    Singapore: Cash course

    The city-state is working hard to become a global wealth management hub, and law firms are gearing up for a prosperous new world

View more analysis from The Lawyer


5 New Street Square

Turnover (£m): 241.20
No. of lawyers: 860 (UK 200)
Jurisdiction: UK
No. of offices: 6
No. of qualified lawyers: 73 (International 50)
No. of partners: 29